Catriona Yale, Chief Development Officer: Akero Therapeutics AKRO Sell · Filed 25/06/12

Trade details

Type: Insider sale
Amount: $151,362
Shares · price: 2,803 sh · $54.00 a share
Held after: 92,231 sh
Stock: Akero Therapeutics AKRO
Person: Catriona YaleChief Development Officer
Trade date: 25/06/10
Filed: 25/06/12
Days to filing: 2 days

Sold 2.9% of holdings

Share of holding sold: 2.9%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/11~25/07/10

Catriona Yale's recent trades

Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$28.4K
659 sh
$28.4K
Filed 25/09/12
Traded 25/09/11
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$457.7K
8,658 sh
$457.7K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$71.8K
1,342 sh
$71.8K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$89.6K
1,633 sh
$89.6K
Filed 25/06/20
Traded 25/06/18
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$334K
6,210 sh
$334K
Filed 25/06/20
Traded 25/06/16